Physician profile
Angel Leake
NPI 1679729842
$8,120.56
in general payments reported to CMS, 2019-2025
15 companies · $1,437 in 2025
The $1,437 reported for 2025 was more than what 82% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,556 · 2020: $1,212 · 2021: $712 · 2022: $537 · 2023: $700 · 2024: $967 · 2025: $1,437.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $2,909.93 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $2,364.40 | 2019-2025 | Dovato, Apretude, Cabenuva |
| Abbvie INC. | $735.17 | 2019-2024 | |
| Janssen Biotech, INC. | $552.84 | 2019-2023 | Symtuza |
| Napo Pharmaceuticals INC | $533.10 | 2019-2024 | Mytesi |
| Emd Serono, INC. | $333.33 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $162.09 | 2019-2020 | |
| Janssen Products, LP | $158.98 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $153.83 | 2019-2020 | |
| Novo Nordisk INC | $111.23 | 2022 | |
| Pfizer INC. | $35.28 | 2022 | |
| Hologic Sales and Service, LLC | $25.21 | 2024 | Aptima |
| Exact Sciences Corporation | $18.61 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $13.65 | 2022 | |
| Phadia US INC. | $12.91 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Leake listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.